Predictors of Response to Direct Acting Anti-Viral Therapy in Patients With Decompensated Hepatitis C Cirrhosis

被引：0
|
作者：
Debnath, Prasanta, II
Chandnani, Sanjay
Rathi, Pravin
Nair, Sujit
Udgirkar, Suhas
机构：
[1] Topiwalla Natl Med Coll, Mumbai, Maharashtra, India
[2] BYL Nair Charitable Hosp, Mumbai, Maharashtra, India
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000593444.12705.94
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
977
引用
收藏
页码：S568 / S568
页数：1
相关论文
共 50 条
  • [31] Hepatocellular carcinoma development in hepatitis C virus patients who achieved sustained viral response by interferon therapy and direct anti-viral agents therapy
    Nagaoki, Yuko
    Imamura, Michio
    Nakamura, Yuki
    Morio, Kei
    Nakahara, Takashi
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Chayama, Kazuaki
    Miki, Daiki
    HEPATOLOGY, 2017, 66 : 629A - 629A
  • [32] Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy
    Banerjee, D.
    Reddy, K. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (06) : 674 - 696
  • [33] Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy
    Miller, M. H.
    Agarwal, K.
    Austin, A.
    Brown, A.
    Barclay, S. T.
    Dundas, P.
    Dusheiko, G. M.
    Foster, G. R.
    Fox, R.
    Hayes, P. C.
    Leen, C.
    Millson, C.
    Ryder, S. D.
    Tait, J.
    Ustianowski, A.
    Dillon, J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (12) : 1363 - 1375
  • [34] Regression of liver stiffness (LS) after direct acting anti-viral (DAA) therapy for hepatitis C in the country of Georgia
    Dolmazashvili, Ekaterine
    Abutidze, Akaki
    Karchava, Marine
    Sharvadze, Lali
    Chkhartishvili, Nikoloz
    Tsertsvadze, Tengiz
    HEPATOLOGY, 2017, 66 : 818A - 818A
  • [35] Predictive features of clinical improvement or deterioration for patients with decompensated hepatitis C cirrhosis after direct acting antiviral therapy
    Jiang, Z. Gordon
    El-Sherif, Omar
    Tapper, Elliot B.
    Charlton, Michael
    Manns, Michael P.
    Afdhal, Nezam H.
    Osinusi, Anu O.
    Huang, K. C.
    Terrault, Norah
    Curry, Michael P.
    HEPATOLOGY, 2017, 66 : 573A - 574A
  • [36] Improvement of neutrophil function in hepatitis C patients under direct acting anti-viral treatment is associated with hemolysis parameters
    Komarova, Irina
    Leber, Bettina
    Horvath, Angela
    Posch, Andreas
    Streit, Andrea
    Spindelboeck, Walter
    Stiegler, Philipp
    Stauber, Rudolf E.
    Stadlbauer, Vanessa
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E226 - E226
  • [37] PREDICTORS OF POOR FIBROSIS REGRESSION AFTER DIRECT ACTING ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND CIRRHOSIS
    Prakash, Shaurya
    Rockey, Don C.
    GASTROENTEROLOGY, 2020, 158 (06) : S1302 - S1303
  • [38] Survival Benefit of Direct Acting Antiviral Therapy in Patients with Decompensated Cirrhosis
    Kim, W. Ray
    Mannalithara, Ajitha
    Lee, Hae Won
    Osinusi, Anu O.
    Schall, Raul E. Aguilar
    Brainard, Diana M.
    HEPATOLOGY, 2017, 66 (06) : 1270A - 1271A
  • [39] Anti-Viral Therapy for Compensated Liver Cirrhosis Patients with Normal Alanine Aminotransferase Response
    Lee, Junggyu
    Sinn, Dong Hyun
    Paik, Seung Woon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2016, 31 (05) : 825 - 826
  • [40] NUTRITIONAL IMPACT OF ANTI-VIRAL THERAPY OF GENOTYPE 1 HEPATITIS C PATIENTS
    Bennett, J.
    Young, K.
    Dundas, P.
    English, S.
    Mcleman, L.
    Vijayan, B.
    Fraser, A.
    Mukhopadhya, A.
    GUT, 2014, 63 : A246 - A247
12345